Explore CASI Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CASI. CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical ...
Short interest in CASI Pharmaceuticals Inc (NASDAQ:CASI) decreased during the last reporting period, falling from 37.05K to 36.10K. This put 0.33% of the company's publicly available shares short.
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback